Article
HSV-1 vector-delivered FGF2 to the retina is neuroprotective but does not preserve functional responses.
Molecular therapy : the journal of the American Society of Gene Therapy - 1 May 2001
Spencer B, Agarwala S, Gentry L, Brandt C R
Abstract excerpt
Fibroblast growth factor 2 (bFGF, FGF2) exhibits mitogenic, angiogenic, wound healing, and neuroprotective properties. Infusion of FGF2 in vivo to treat neurodegenerative disorders in animal models results in increased survival of damaged neurons, but these effects are transient. To test the feasibility of HSV vector-delivered FGF2 for neuroprotection, we inserted the FGF2 gene under the control of the HCMV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
